And the brand manager of the drug is in charge of selecting a technology solution, so the customer concentration risk is lower than the number of big pharma logos PAYS has. Generally, the program ...

PONT-DU-CHÂTEAU, France, Nov. 20, 2024 /PRNewswire/ -- Dômes Pharma Group has officially renamed SentrX Animal Care as Dômes Pharma, Inc. in the U.S., strengthening its global brand presence. This ...

TD Securities lowered the firm’s price target on CCL Industries (CCDBF) to C$94 from C$98 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source for real-time ...

An employee checks equipment at a pharmaceutical plant in Lianyungang, Jiangsu province. GENG YUHE/FOR CHINA DAILY BEIJING -- China has highlighted its commitment to encouraging the long-term ...

More information is available at the Company's website at www.amphastar.com. The Amphastar Pharmaceuticals' logo and other trademarks or service marks of Amphastar Pharmaceuticals, Inc., ...

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 13, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration ...

CCL Industries (A) (TSE:CCL.A) has released an update. CCL Industries reported a strong performance for the third quarter of 2024, with a 9.4% rise in sales driven by organic growth, acquisitions ...

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 13, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, ...

Ramaswamy’s primary source of wealth is Roivant Sciences, a biotech company he founded in 2014. His business strategy centers on acquiring and developing overlooked pharmaceuticals, which are then ...

a subsidiary of CCL Pharmaceuticals, submitted a public announcement of intention (PAI) to acquire a 50% stake and controlling interest in the Pakistani manufacturer of farm and confectionery ...

German pharmaceutical giant Bayer released its third quarter 2024 earnings on Tuesday, reporting net sales of €10.0bn, down from €10.3bn in the same period last year. The company’s share ...

The pharma giant has hired Goldman Sachs to gauge initial interest from potential buyers, which include private equity firms and other pharmaceutical companies, the sources said, requesting ...